We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
1 own
6 watching
Current Price
$0.92
$0.01
(1.37%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
185.8M
52-Week High
5.4309
52-Week Low
0.86
Average Volume
0.05M
Dividend Yield
--
P/E Ratio
--
Market Capitalization185.8M
52-Week High5.4309
52-Week Low0.86
Average Volume0.05M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company s lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Globe Newswire
17days ago
Menlo Park, California, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the third quarter and nine months ended September 30, 2022. Financial Highlights...
PR Newswire
3 months ago
Thinking about buying stock in Signify Health, Summit Therapeutics, Party City, XORTX Therapeutics, or NightHawk Biosciences? Thinking about buying stock in Signify Health, Summit Therapeutics, Party City, XORTX Therapeutics, or NightHawk Biosciences? PR Newswire NEW YORK, Aug. 22, 2022 NEW YORK...
PR Newswire
3 months ago
Thinking about buying stock in Summit Therapeutics, AMC Entertainment, System1, Bed Bath & Beyond, or Plug Power? Thinking about buying stock in Summit Therapeutics, AMC Entertainment, System1, Bed Bath & Beyond, or Plug Power? PR Newswire NEW YORK, Aug. 19, 2022 NEW YORK, Aug. 19...
Globe Newswire
3 months ago
Menlo Park, California, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the second quarter ended June 30, 2022. Financial Highlights Aggregate cash, ...
Ticker Report
3 months ago
StockNews.com began coverage on shares of Summit Therapeutics (NASDAQ:SMMT Get Rating) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the stock. Summit Therapeutics Stock Performance Shares of SMMT opened at $0.97 on Tuesday. The firm has a market ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$0.92
$0.01
(1.37%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00